A detailed history of Americana Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Americana Partners, LLC holds 14,803 shares of AMGN stock, worth $3.9 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
14,803
Previous 14,947 0.96%
Holding current value
$3.9 Million
Previous $4.67 Million 2.12%
% of portfolio
0.35%
Previous 0.4%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$309.38 - $337.38 $44,550 - $48,582
-144 Reduced 0.96%
14,803 $4.77 Million
Q2 2024

Jul 30, 2024

BUY
$262.75 - $319.31 $549,673 - $667,996
2,092 Added 16.27%
14,947 $4.67 Million
Q1 2024

May 07, 2024

BUY
$268.87 - $324.56 $201,921 - $243,744
751 Added 6.2%
12,855 $3.65 Million
Q4 2023

Jan 25, 2024

BUY
$255.7 - $288.46 $1.15 Million - $1.29 Million
4,488 Added 58.93%
12,104 $3.49 Million
Q3 2023

Nov 07, 2023

BUY
$218.65 - $271.46 $689,622 - $856,184
3,154 Added 70.69%
7,616 $2.05 Million
Q2 2023

Jul 31, 2023

BUY
$214.27 - $253.37 $202,485 - $239,434
945 Added 26.87%
4,462 $990,000
Q1 2023

May 08, 2023

BUY
$225.79 - $275.2 $49,673 - $60,544
220 Added 6.67%
3,517 $850,000
Q4 2022

Jan 30, 2023

BUY
$229.03 - $291.01 $15,574 - $19,788
68 Added 2.11%
3,297 $865,000
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $3,815 - $4,303
17 Added 0.53%
3,229 $721,000
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $276,852 - $308,088
1,200 Added 59.64%
3,212 $747,000
Q1 2022

May 06, 2022

BUY
$219.27 - $242.57 $441,171 - $488,050
2,012 New
2,012 $460,000
Q4 2021

Jan 28, 2022

SELL
$198.88 - $227.6 $269,880 - $308,853
-1,357 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $288,050 - $337,485
1,357 New
1,357 $288,000
Q1 2020

May 12, 2020

SELL
$182.24 - $241.7 $157,819 - $209,312
-866 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $163,855 - $210,611
866 New
866 $208,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Americana Partners, LLC Portfolio

Follow Americana Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Americana Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Americana Partners, LLC with notifications on news.